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SUMMARY
We analysed data on laboratory or epidemiologically confirmed cases (n=856539) and on
outbreaks (n=31644) notified during week 31 (2001) to week 30 (2009), and performed
molecular typing of specimens from 665 outbreaks. We aimed at identifying demographic and
molecular characteristics to inform on potential additional approaches to prevent disease spread
in the population. The mean incidence by norovirus season (week 31 in one year to week 30 in
the following year) was 130 (range 19–300) cases/100000 population and was highest in persons
aged <5 years (430/100000) and 575 years (593/100000). The proportion hospitalized in
community-acquired cases was 8–19% per season. The mean norovirus-associated mortality was
0·05/100000 per season and 0·5/100000 in the 575 years age group. Most outbreaks with known
setting (75%) occurred in hospitals (32%), nursing homes (28%), households (24%) and childcare
facilities (10%). GII strains dominated in the outbreak specimens. GII.4 strains were found in
82% of nursing home outbreaks, 85% of hospital outbreaks, and 33% of childcare facility and
school outbreaks. Cases in younger individuals were notified earlier during the season than adult
cases, and outbreaks in childcare facilities and schools preceded those in nursing/residential
homes, hospitals and private households. We suggest future studies to investigate more closely
potential transmission patterns between children and adults.
Key words: Infectious disease epidemiology, Norwalk agent and related viruses, notifiable infectious
diseases, outbreaks, surveillance.
INTRODUCTION
Noroviruses are the most frequent cause of acute
gastroenteritis in both sporadic community and out-
break cases [1, 2]. The disease is usually self-limiting,
of short duration and characterized by vomiting
and diarrhoea, but symptoms can persist longer in
vulnerable populations such as the elderly [3] or im-
munocompromised [4]. Large outbreaks often occur
in community facilities such as hospitals, nursing
homes for the elderly, and childcare facilities [5].
Due to a high genetic diversity, noroviruses segregate
into five genogroups. The three human pathogenic
genogroups (GI, GII, GIV) are further divided
into at least 30 different genotypes [6]. The majority
of worldwide epidemics have been caused by drift
variants of genotype II.4 [7, 8].
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In Germany, norovirus gastroenteritis is a notifiable
illness according to the Protection Against Infection
Act of 2001 and nationwide surveillance data are
available in an electronic database at the Robert
Koch Institute (RKI), which is the public health insti-
tute at the national level.
Here, we describe eight seasons of norovirus sur-
veillance in Germany in order to identify demographic
and molecular characteristics to inform on potential




In Germany, laboratory detection of norovirus infec-
tion as well as cases of suspected infectious gastro-
enteritis or food poisoning, if occurring in food
handlers or in outbreaks, are notifiable to the local
public health departments (LPHD). Not only are
health professionals required to report cases but also
the heads of institutional facilities (e.g. residential
homes, nurseries), pilots, ship captains, etc.
For every reported person meeting the surveillance
case definition (see below), the LPHD completes an
electronic case report which is transmitted (without
the name and address of the patient) to the RKI via
one of the 16 state health departments. Cases occur-
ring within an outbreak can be linked in an electronic
outbreak report at the local, the federal state or
the national level of the public health system. The
outbreak report contains details on the outbreak
(e.g. setting, suspected vehicle of infection, evidence
for suspected vehicle) and is integrated into the
electronic reporting system.
In the analysis we included cases of norovirus
gastroenteritis if they met the national surveillance
case definition [9] which comprises cases with gastro-
enteritis symptoms (vomiting or diarrhoea, i.e. 53
loose stools within 24 h, or as diagnosed by the patient
or healthcare personnel) with laboratory or epidemio-
logical confirmation. Laboratory confirmation is
defined as a positive result of either PCR, ELISA
(from stools only) or electron microscopy. A case is
considered epidemiologically confirmed by an epide-
miological link to a laboratory-confirmed case
through person-to-person transmission or through
a common exposure (e.g. food). Alternatively, the
reported consumption of a laboratory-confirmed
norovirus-contaminated product also allows the
establishment of an epidemiological link. We describe
all reported outbreaks with at least two cases meeting
the case definition and with at least one laboratory-
confirmed case.
Notification data on cases and outbreaks were
extracted from the national surveillance database as
of 1 January 2011. We included all cases reported
between week 31 (2001) and week 30 (2009) in our
analysis. After this notification period, information
on cases that are only epidemiologically confirmed is
no longer forwarded from the LPHD to the RKI
and a comparison between seasons based on all
cases can no longer be made. The incidence of
reported norovirus gastroenteritis by season was
calculated using the information on the German
population size provided by the statistical offices of
the federal states. We defined the start of an outbreak
as the week the first case in the outbreak was reported.
Since norovirus activity peaks during winter, a season
was considered to range from week 31 in one year to
week 30 in the following year. We considered cases
with disease onset 51 day after hospital admission
as potentially nosocomial cases.
Laboratory data
For genotyping of noroviruses circulating in
Germany, we analysed stool specimens from
norovirus-positive outbreaks sent to the Consultant
Laboratory for Noroviruses (CL) by diagnostic lab-
oratories, physicians and local public health auth-
orities at their convenience. For sequencing, PCR
products of region A in the RNA-dependent RNA
polymerase gene (ORF1) and region C in the 5′ term-
inal part of the capsid gene (ORF2) were used [10].
Sample processing, amplification, and sequencing of
region A were performed as described previously
[11, 12]. For amplification and sequencing of region
C, primers specific for GI and GII were used
(Table 1). Amplicons were sequenced directly using
the BigDye terminator cycle sequencing kit and an
ABI 3130xI Genetic Analyzer (Applied Biosystems,
USA). Sequences were aligned to prototype sequences
drawn from GenBank with use of CLUSTAL W,
version 1.6, and phylogenetic trees were produced
using the neighbour-joining and DNADIST program
of the Phylogeny interference package (PHYLIP),
version 3.57c [13].
All statistical analyses were performed with Stata
v. 12 (StataCorp, USA).
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RESULTS
Time trend
From season 2001/2002 to season 2008/2009, a
total of 856539 norovirus cases were reported in
Germany. The case number by season varied between
15414 in 2001/2002 and 246800 in 2007/2008, corre-
sponding to a mean incidence per season of 130
(range 19–300) cases/100000 population (Table 2).
Notification data show a strong, single-peak seasonal-
ity with the majority (76%) of cases occurring between
November and March. Case numbers increased
over the seasons and remained at a high level since
2006/2007 (Fig. 1).
On average, 49% of cases were laboratory-
confirmed ranging from 31% in 2002/2003 to 58% in
2008/2009. Of the cases with laboratory confirmation,
66% were laboratory-confirmed only, whereas 34%
were also epidemiologically confirmed. The pro-
portion of laboratory-confirmed cases differed within
each season. It was high during the months with
lower incidences at the end of each season (July:
65%) and low during the high season (December:
41%).
Seventy-six percent of cases were reported in out-
breaks ranging from 56% in 2003/2004 to 87% in
2001/2002 (Table 2, Fig. 1), with variations between
summer (July: 43%) and winter (November–January:
74%).
Cases in children aged 0–5 years and in pupils aged
6–17 years were notified earlier during the season than
cases in socially active adults (18–74 years) and the
socially less active elderly (575 years, Fig. 2). In the
two youngest age groups, 25% of cases were notified
by weeks 18 and 19, respectively, compared to week
21 in the two older age groups. This delay between
the younger and older age groups was seen throughout
all seasons but was less pronounced in seasons
2002/2003 and 2007/2008.
Demographic distribution
The mean incidence by season was 162/100000 popu-
lation (range 24–368) in females and 96/100000 popu-
lation (range 13–228) in males. It was highest in
children aged <5 years (430/100000 population) and
in persons aged 575 years (289–1198/100000 popu-
lation). While among children boys were slightly
more affected than girls, in the elderly a higher inci-
dence was seen in women than in men (Fig. 3).
The cases’ median age was 62 years [interquartile
range (IQR) 25–82 years]. Female cases were older
than male cases (median age 70 vs. 50 years, IQR
34–84 vs. 7–74 years) and occurred more often in out-
breaks (72 vs. 59%).
Clinical aspects
Of cases with information (98%), 230057 were hospi-
talized. For 130176 (57%) of these, information on
date of symptom onset and of hospitalization was
available. Of these, 50% had symptom onset 51 day
after hospital admission and were thus considered
nosocomial cases. The minimum proportion of non-
nosocomial, i.e. community-acquired, hospitalized
norovirus gastroenteritis in all cases was therefore
8% (3% in season 2003/2004 to 9% in 2008/2009).
The maximum proportion was 19% (9% in 2001/
2002 to 23% in 2008/2009), assuming that all cases
with missing information had community-acquired
disease (Table 2). The proportions were 2–10% in
children aged <6 years, and 11–24% in ≥75-year-olds.
Table 1. Primers used for amplification and sequencing of genogroup (G) I and GII, and of region C (capsid gene
fragment)
Genogroup Round Primer Sequence (5′–3′)
GI First NV192 (s) GCYATGTTCCGCTGGATGC
NV285 (as) CCAACCCARCCATTRTACAT
Second NV192 (s) GCYATGTTCCGCTGGATGC
NV300/I (as) TGRGGIGCYTGIACAAAATT
GII First NV107c (s) AICCIATGTTYAGITGGATG
NV156 (as) ACCKGCATAACCATTRTACAT
Second NV107c (s) AICCIATGTTYAGITGGATG
NV300/II (as) CYAGGKGCYTGIACAAARTT
I, Inosin; Y=C/T; R=A/G; K=G/T.
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Table 2. Characteristics of norovirus seasons 2001/2002 to 2008/2009, Germany
Season
2001/2002 2002/2003 2003/2004 2004/2005 2005/2006 2006/2007 2007/2008 2008/2009 All
No. of cases 15414 72575 30501 93438 53464 146805 246800 197542 856539
Incidence (cases/100000 population) 18·7 87·9 37·0 113·3 64·9 178·3 300·2 240·9 130·1
Laboratory-confirmed cases (%) 33 31 55 53 38 43 52 58 49
Minimum/maximum community-acquired cases
hospitalized (%)
4–9 5–14 3–10 6–16 5–13 8–20 9–22 9–23 8–19
Deceased cases (%) 0·12 0·11 0·03 0·03 0·02 0·04 0·04 0·02 0·04
Female cases (%) 66 71 63 64 65 65 63 61 64
Median age of cases, years (IQR) 48 (14–81) 71 (39–84) 41 (7–76) 54 (20–80) 53 (18–81) 68 (32–83) 64 (25–82) 61 (23–81) 62 (25–82)
Median season week* of reporting (IQR) 34 (26–41) 22 (18–28) 32 (21–38) 24 (19–31) 31 (24–36) 28 (23–35) 25 (20–30) 27 (21–32) 26 (21–33)
Cases in outbreaks (%) 88 83 56 60 73 65 60 67
No. of outbreaks with sample at CL (%) 71 (100) 135 (100) 27 (100) 71 (100) 61 (100) 140 (100) 88 (100) 72 (100) 665 (100)
GI 6 (8) 4 (3) 3 (11) 3 (4) 0 (0) 11 (8) 12 (14) 6 (8) 45 (7)
GII 65 (92) 131 (97) 24 (89) 67 (94) 59 (97) 128 (91) 74 (84) 65 (90) 613 (92)
GI+II 0 (0) 0 (0) 0 (0) 1 (1) 2 (3) 1 (1) 2 (2) 1 (1) 7 (1)
GII.4 43 (61) 127 (94) 9 (33) 60 (85) 16 (26) 104 (74) 58 (66) 50 (69) 467 (70)
G, Genogroup; IQR, interquartile range.
Note that data above and below the horizontal line are from two different sources: the electronic reporting system and the Consultant Laboratory for Noroviruses (CL),
respectively.
* Season week 1 corresponds to calendar week 31, season week 21 to calendar week 52, season week 22 to calendar week 1 (in season 2004/2005 season week 23 corresponds








Of cases with information (99%), a total of 326
deaths associated with norovirus gastroenteritis were
reported which corresponds to a mean mortality of
0·05/100000 population by season (range 0·01–0·11).
It was comparable between females and males (0·06
vs. 0·04/100000, range 0·01–0·13 vs. 0·01–0·08) and
considerably higher (0·5/100000, range 0·1–1·1) in
persons aged ≥75 years. Deceased cases had a median
age of 84 years (IQR 78–90 years) compared to 62
years (IQR 24–82 years) for non-deceased cases. The
proportion of deceased cases was the same (0·04%)
in sporadic and outbreak cases.
Geographical distribution
Of the cases with information (95%), almost
all (99·7%) were reported to have acquired the
infection in Germany. The mean incidence by season
ranged from 82/100000 population in the federal
state of Bavaria to 287/100000 population in
Saxony. It was considerably higher in the Eastern
(222–287/100000 population, except for Berlin)
than in the Western (82–183/100000 population)
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Fig. 2. Weekly cumulative proportion of notified cases by age group, Germany, seasons 2001/2002 to 2008/2009. Season
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Fig. 1. Monthly incidence of reported norovirus cases by confirmation status and monthly proportion of sporadic cases,
Germany, seasons 2001/2002 to 2008/2009.
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In the East, the proportion of all hospitalized
cases was lower than in the West (20% vs. 31%)
but was comparable when looking at hospitalized
community-acquired illness (minimum/maximum
proportions 9%/12% vs. 7%/23%). The proportion of
deceased cases was lower in the East (0·01 vs.
0·05%), as was the median age of cases (54 vs. 67
years, IQR 10–80 vs. 31–82 years). The proportion
of laboratory-confirmed cases was comparable (51%
vs. 48%).
Outbreaks
We considered 31644 reported norovirus outbreaks
for our analyses giving a total of 552823 cases. In
accordance with case numbers by season, the number
of outbreaks increased from 646 in season 2001/2002
to 9753 in season 2007/2008 (Fig. 4).
Of the outbreaks with a reported setting (75%), half
occurred in nursing homes or hospitals followed by
outbreaks in private households and childcare facili-
ties. Outbreaks in schools or universities, residential
homes (for children, adolescents, university students,
soldiers), hotels, cruise ships, youth camps, and
restaurants/canteens were rarely reported (Table 3).
The median case number per outbreak was nine
(IQR 3–23). Outbreaks in nursing homes were larger
than outbreaks in hospitals, childcare facilities or
private households. Of the cases in the 31644 out-
breaks, a median of two (IQR 1–5) were laboratory-
confirmed, corresponding to a median of 33% (IQR
14–63%) of cases. The median proportion of
laboratory-confirmed cases depended on the outbreak
setting and was low in nursing homes (14%) and
childcare facilities (17%), higher in hotel outbreaks
(35%) and highest in private households, restaurants/
canteens and hospitals (50%). The median age of
cases per outbreak was 67 years (IQR 24–80 years)
and reflected the expected age of persons represented
in the respective settings. The proportion of female
cases was high (80%) in nursing home outbreaks,
whereas the sex distribution was more comparable in
all other settings (Table 3).
Similar to the results from case data, outbreaks in
childcare facilities and schools occurred 5–6 weeks
earlier in the norovirus season than outbreaks in
other settings with sufficiently high outbreak numbers
during the study period, i.e. in nursing homes, hospi-
tals and private households (Table 3). This trend
was seen throughout all seasons except for seasons
2001/2002 and 2002/2003, during which only one
outbreak in a childcare facility was reported.
For 799 (3%) outbreaks a link to a specific food





























































Fig. 3. Mean incidence of reported norovirus cases per season by age group and sex, Germany, seasons 2001/2002 to
2008/2009.
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the outbreak setting and was highest for restaurant
and canteen outbreaks (46%, n=66) and for outbreaks
in hotels, on cruise ships or in youth camps (9%,
n=19).
Molecular characteristics of outbreaks
From August 2001 to July 2009, a total of 996 clinical
specimens from 665 norovirus outbreaks were geno-
typed at the CL. In 92% of the outbreaks, norovirus
genogroup GII was identified, ranging from 84%
in season 2007/2008 to 97% in seasons 2002/2003
and 2005/2006 (Table 2). GI strains were identified
in 7% of all outbreaks, and in 1% of outbreaks both
genogroups were found.
GII strains dominated outbreaks in all reported set-
tings, but GI strains were found in a higher proportion
of outbreaks in childcare facilities, schools, hotels,
cruise ships and youth camps than in other settings
(Table 3). Whereas GI strains were found in outbreaks
occurring all year round, i.e. also during summer, GII
strains showed a stronger seasonality and were more
often found during winter (Fig. 5a).
Most GII outbreaks were associated with genotype
GII.4 (76%) followed by GII.7 (10%), recombinant
GII.b/GII.3 (7%), and GII.2 (3%). The highest pro-
portion of outbreaks with GII.4 was found in season
2002/2003 (94%, Table 2), compared to only 26% in
season 2005/2006 when genotype GII.7 (51%) domi-
nated. In 2003/2004 recombinant GII.b/GII.3 (42%)
was the most frequently detected strain (Fig. 5a).
The proportion of GII.4 outbreaks was 82%
(174/211) in nursing homes and 85% (203/239) in hos-
pitals, but only 33% (45/138) in childcare facilities and
schools (Table 3).
Starting from 2002, several GII.4 variants emerged
in Germany, became predominant and were replaced
by the next emerging variant (Fig. 5b).
DISCUSSION
We have described data on over 850000 cases and
31000 outbreaks from eight seasons of norovirus
surveillance in Germany. Our data include detailed
information on laboratory and epidemiologically
confirmed cases. This has been a unique feature of
the German norovirus surveillance system from 2001
to 2009 compared to other countries where surveil-
lance focuses on outbreak surveillance or laboratory
reports [14, 15].
Our incidences per season are lower than estimates
of 4500–6500 cases/100000 person-years from the
USA and UK [16–18] and of 3800 cases/100000 popu-
lation from The Netherlands [19], and also lower than
1665 cases/100000 children aged <5 years in industri-
alized countries from a systematic literature review on
sporadic gastroenteritis [2]. This is plausible because
our passive surveillance system probably under-
estimates the true incidence of norovirus disease
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Fig. 4. Distribution of settings of reported norovirus outbreaks (n=31644) by year and month of reporting, Germany,
seasons 2001/2002 to 2008/2009.
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No. of outbreaks (%) 6768 (28) 7674 (32) 2384 (10) 5730 (24) 148 (<1) 314 (1) 223 (<1) 145 (<1) 402 (2)
Median case no. (IQR) 22 (11–38) 10 (5–21) 13 (8–20) 3 (2–4) 20 (10–35) 12 (7–20) 5 (2–15) 6 (3–14) 7 (3–16)
Median no of laboratory-confirmed
cases (IQR)
3 (2–5) 4 (2–9) 2 (1–3) 1 (1–2) 2 (1–4) 2 (1–4) 2 (1–3) 3 (2–5) 2 (1–4)
Median% cases female (IQR) 80 (70–87) 62 (50–75) 50 (42–63) 50 (33–67) 50 (40–59) 57 (43–71) 50 (43–67) 50 (33–67) 50 (33–67)
Median age of cases, years (IQR) 82 (77–84·5) 73 (62–79) 4 (2–4·5) 25 (14–38) 10 (8–16·25) 43·5 (29–54) 29·5 (15–58) 41 (32–47·5) 37·5 (21–52)
Foodborne outbreaks (%) 3 2 2 5 7 3 9 46 9
Median season week* of outbreak
start (IQR)
26 (22–32) 26 (21–32) 21 (17–29) 27 (20–33) 21 (18–29·5) 27 (21–33) 27 (13–43) 24 (19–38) 26 (19–35)
No. of outbreaks with sample
at CL (% of total)
211 (100) 239 (100) 138 (100) 8 (100) † ‡ 6 (100) 5 (100) 56 (100)
GI 12 (6) 4 (2) 18 (13) 0 (0) 1 (17) 0 (0) 8 (14)
GII 197 (93) 233 (97) 119 (86) 8 (100) 5 (83) 5 (100) 46 (82)
GI+II 2 (1) 2 (1) 1 (1) 0 (0) 0 (0) 0 (0) 2 (4)
GII.4 174 (82) 203 (85) 45 (33) 4 (50) 4 (67) 2 (40) 35 (63)
G, Genogroup; IQR, interquartile range.
Note that data above and below the horizontal line are from two different sources: the electronic reporting system and the Consultant Laboratory for Noroviruses (CL),
respectively.
* Season week 1 corresponds to calendar week 31, season week 21 to calendar week 52, season week 22 to calendar week 1 (in season 2004/2005 season week 23 corresponds to
calendar week 1 due to 53 calendar weeks in 2004), etc. (see Methods section).
† School outbreaks included in ‘childcare facility’.








population, who do not consult the healthcare system
for uncomplicated acute gastroenteritis.
The proportion of hospitalized cases of community-
acquired illness was 8–19%. The true proportion,
which we assumed to be around 13% (6% in <6 year-
olds, 17% in >74-year-olds), is considerably higher
than the 0·7% reported in a review of published out-
breaks which excluded hospital outbreaks [20] and
the 0·03% estimated for foodborne norovirus illness
[21]. Moreover, the proportion in <6-year-olds is
lower than the 12% reported for children aged
<5 years with sporadic gastroenteritis [2]. However,
the population underlying published outbreak reports
differs substantially from the population covered by
our routine surveillance, and only a small percentage
of our outbreaks were reported to be foodborne;
therefore, comparability with results from the above-
mentioned publications is limited. It is unlikely
that norovirus cases are hospitalized more often
in Germany than in other countries. It is more
likely that our surveillance system under-ascertained
uncomplicated community-acquired cases which es-
cape the attention of the healthcare system leading
to a higher proportion of hospitalized cases. The
increasing proportion of hospitalized cases over time
can be explained by the increasing number of out-
break reports from nursing homes where the residents
are more likely to be prone to more severe courses of
disease. Additionally, in this setting awareness and
testing for norovirus is probably increased.
The relatively constant proportion of fatal cases
over time (mean: 0·04%) also supports the notion
that norovirus disease severity is not increasing over
time. Our results are comparable to the 0·03% in long-
term care facilities in Australia [22] and the 0·07%
described in a review of published outbreaks [20], con-
sidering that our dataset includes sporadic cases that
are younger and less likely to develop complications.
Our mortality rate of 0·5/100000 cases per season
in the elderly (575 years) is lower than modelling
estimates from the USA, UK and The Netherlands
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Fig. 5. (a) Monthly distribution of norovirus genotypes, August 2001–July 2009 and (b) distribution of genotype II.4
variants in seasons 2001/2002 to 2008/2009 in outbreaks with samples analysed at the Consultant Laboratory for
Noroviruses (CL). n, Total number of samples at CL; GII other=II.5, II.8, II.12, II.14, II.20, GII/GI mix; GII recomb=
II.b, II.d, II.e, II.g.
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[3, 23, 24], but comparable when considering that the
surveillance system captures only half of norovirus-
associated deaths compared to the German cause-
of-death statistics [25].
We found that norovirus incidence and mortality
were higher in females than in males, and female
cases were older than male cases. These findings can
be explained by the higher proportion of females in
nursing homes, where the risk of infection during
the norovirus high season as well as the likelihood of
outbreaks being recognized might be higher than in
other settings.
The incidence in the Eastern German federal states
was higher than in the Western states. Considering the
findings that cases in the East are younger (especially
sporadic laboratory-confirmed cases, data not shown)
and the proportion of deceased cases is lower, we
believe that the higher reporting incidences reflect a
different behaviour regarding medical consultation
and laboratory testing rather than a true difference
in incidence.
The increase in case numbers from 2001/2002 to
2006/2007 has also been reported in other countries
and is in part probably due to the increased worldwide
circulation of GII.4 strains [26] resulting in synchro-
nized norovirus epidemics in Europe, USA, and
Canada [7]. GII.4 strains have been reported to
cause more severe illness [20, 27] and a higher viral
load in infected persons than other strains [28],
which may lead to more frequent disease transmission.
A higher environmental stability has also been dis-
cussed [26]. However, increased awareness for noro-
virus entailing more laboratory testing, and the
availability of more sensitive tests such as real-time
RT–PCR [1] have probably also contributed to
increasing case numbers in the early 2000s. The
increasing proportion of laboratory-confirmed cases
over the eight seasons could support this notion, but
from anecdotal reports we attribute this to an under-
ascertainment of epidemiologically confirmed cases
in the context of large norovirus epidemics implying
a high workload.
Interestingly, we found that the norovirus season
started earlier in the younger (<18 years) than in the
older age groups which was supported by case-based
as well as outbreak data. Whether this reflects a pat-
tern of disease transmission from young to old in the
community should be investigated in further studies.
One outbreak investigation from Sweden found chil-
dren to be more likely to cause secondary cases [29].
Whether this is linked to the longer symptomatic
period [30] or the higher frequency of vomiting in chil-
dren [31] is unclear. It is subject to controversy
whether vomiting poses a higher risk of norovirus
transmission than other routes of transmission [32].
An alternative explanation for the observed antece-
dence of children each season could be that the strains
causing disease in the younger age groups differ from
those in adults implying that epidemiological patterns
in children and adults are not necessarily related to
each other. In our convenience sample, outbreaks in
childcare settings were less frequently caused by
GII.4 (and more frequently by GI) strains than hospi-
tal and nursing home outbreaks, which corresponds to
a recent publication that reported a higher frequency
of GII.4 strains in outbreaks in healthcare settings
than in outbreaks involving younger persons [5].
Findings from France suggest that GII noroviruses
are more common in sporadic cases whereas GI
strains are predominant in outbreaks in children [33].
The distribution of our outbreak settings differed
from that in other countries [14, 26, 34, 35]. One prob-
able reason is that our dataset includes a large number
of outbreaks in private households which are not
captured as frequently by other surveillance systems.
This might also explain why, in contrast to outbreak
surveillance data from England and Wales [34],
we found a seasonal variation with a winter peak for
outbreaks in all settings.
The number of foodborne outbreaks in our data-
base is unclear. According to a recent publication
[21] 26% of norovirus illnesses in the USA are food-
borne. In Germany, the LPHD can report an impli-
cated vehicle of infection for each outbreak, but
often no investigation is performed on whether a
norovirus outbreak is primarily foodborne if the
setting (e.g. restaurant) does not imply this. Even in
restaurant and canteen outbreaks only 47% were
reported to be foodborne. However, the proportion
of foodborne outbreaks by outbreak setting in our
dataset roughly resembles data from England and
Wales [34]. We probably underestimated the amount
of foodborne norovirus transmission but cannot quan-
tify it from our data.
There are some limitations to our findings. Routine
surveillance data do not provide the complete picture
of norovirus activity in the population. In particular,
uncomplicated cases and cases without laboratory
confirmation are likely to be under-represented in
our database. We thus underestimated the size of
large outbreaks, e.g. in hospitals and nursing homes
[36], but more importantly we under-ascertained
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small outbreaks in private households and sporadic
community cases as has been shown for the UK
[18]. However, the ratio of median outbreak size by
setting reflects what we expected to find according to
the size of the population at risk in the respective set-
tings and is comparable to outbreak surveillance data
from Australia [22]. We therefore believe that our sur-
veillance data reflect the correct trend of norovirus
activity in the different settings.
A major limitation is that our typing data on out-
breaks come from a convenience sample. We must
assume that this sample might not be representative
for outbreaks in Germany, not only because the distri-
bution of outbreak settings in the laboratory data
(household outbreaks were basically not represented)
differed considerably from that in the routine surveil-
lance data. From our experience, diagnostic labora-
tories, physicians and local public health authorities
send outbreak specimens to the CL not only to ensure
certain diagnostic standards, but also when the out-
break at hand is of special media interest or when
the genogroup is difficult to identify. Therefore out-
breaks that are exceptional in regard to the norovirus
strain involved, disease severity or size are probably
over-represented in the dataset.
In conclusion, our routine surveillance data on
norovirus disease in Germany confirm estimates on
norovirus disease burden from other countries. We
found some evidence for a start of the norovirus
season in younger age groups. More detailed investi-
gation is required in the future on transmission
patterns between children and adults in order to ident-
ify possible starting points for enhanced prevention of
disease spread in the population.
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